with the capital reduction to reduce the Company’s deficit and eliminate the share discount, prompting a final adjustment to the par value of the Company’s ordinary and preferred shares to THB 3.20 per

liabilities 187,661 67% 194,129 76% 37,532 15% Share capital 170,000 61% 170,000 67% 340,000 139% Retained earnings (Deficit) - 0% - 0% - 0% - Legal reserves - 0% - 0% - 0% - Unappropriated (Deficit) (78,869

% 150,111 29% Share capital 500,000 61% 500,000 64% 500,000 90% 500,000 96% Retained earnings (Deficit) - Legal reserves 7,390 1% 9,010 1% 9,910 2% 9,910 2% - Unappropriated (Deficit) 144,152 17% 135,416 17

to approve the cash dividend payment from the operating results of 2H 2017 of THB 0.018 per share (totaling THB 62mn). The total 2017 dividend payout was THB 122mn. The dividend was paid to

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

496.3 million shares, and recognized the total loss of 96.9 MB. Besides, during the period the Company make offset between share premium and deficit as at 31 December 2016 amounting to 207.89 MB. The

Shareholders ' Equity 251.63 202.01 49.62 24.56 Basic Loss Per Share (Baht) -0.36 -0.15 Gross Margin -1.71% 3.04% Net Profit Margin -132.08% -23.48% Debt to Equity Ratio (Time) 3.58 1.78 Total Expenses Summary

to SPP Intelligence Co., Ltd. (the “Purchaser”) at an approximate price of Baht 1.80 per share, amounting to the total of Baht 9,000,000 or the price after adjustment according to the statement of

value of Baht 100 per share, representing 30.00 percent of the issued and paid-up capital of UWM at a price of Baht 25 per share (25 percent of the par value) with a total value of Baht 33.75 million

at a par value of Baht 100 per share, representing 30.00 percent of the issued and paid-up capital of UWM at a price of Baht 25 per share (25 percent of the par value) with a total value of Baht 33.75